STOCK TITAN

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) announced it will report its financial results for the fourth quarter and full year of 2022 on February 23, 2023, before market open. The company's management will host a conference call at 5:30 a.m. PT / 8:30 a.m. ET to discuss the results, business developments, and future outlook. The live webcast will be accessible through the 'Investors' section of its website. Nautilus is focused on developing a single-molecule protein analysis platform aimed at transforming proteomics and enhancing access to proteome data, which has significant implications for human health and medicine.

Positive
  • Future webcast on February 23, 2023, to discuss key financial results and business developments.
  • Nautilus is pioneering a unique protein analysis platform that could advance proteomic research.
Negative
  • None.

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, February 23, 2023.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio 

Investor Contact
investorrelations@nautilus.bio 


FAQ

When will Nautilus Biotechnology report its financial results for 2022?

Nautilus Biotechnology will report its financial results for the fourth quarter and full year of 2022 on February 23, 2023.

What time is Nautilus's conference call scheduled for?

The conference call is scheduled for 5:30 a.m. PT / 8:30 a.m. ET on February 23, 2023.

Where can I access the webcast for Nautilus's financial results?

The webcast will be available on the 'Investors' section of Nautilus Biotechnology's website.

What is the focus of Nautilus Biotechnology's platform technology?

Nautilus is focused on creating a platform technology for quantifying and unlocking the complexity of the proteome.

Nautilus Biotechnolgy, Inc.

NASDAQ:NAUT

NAUT Rankings

NAUT Latest News

NAUT Stock Data

296.03M
125.56M
33.47%
50.18%
0.96%
Biotechnology
Laboratory Analytical Instruments
Link
United States of America
SEATTLE